LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

PHASE I/II STUDY OF CHOEP PLUS LENALIDOMIDE AS INITIAL THERAPY FOR PATIENTS WITH STAGE II‐IV PERIPHERAL T‐CELL LYMPHOMA: PHASE II RESULTS

Photo by umbriferous from unsplash

University Third Hospital, Beijing, China; Department of Hematology, The First Affiliated Hospital of Harbin Medical University, Harbin, China; Department of Hematology, Peking University First Hospital, Beijing, China; Department of Hematology,… Click to show full abstract

University Third Hospital, Beijing, China; Department of Hematology, The First Affiliated Hospital of Harbin Medical University, Harbin, China; Department of Hematology, Peking University First Hospital, Beijing, China; Department of Hematology, Beijing Hospital, Beijing, China; Department of Lymphoma, Harbin Medical University Cancer Hospital, Harbin, China; Lymphoma diagnosis and treatment center, Institute of Hematology and Blood Diseases Hospital, Tianjin, China; Department of Hematology, Second Hospital of Hebei Medical University, Shijiazhuang, China; Department of Hematology, Shanxi Provincial People’s Hospital, Taiyuan, China; Department of Hematology, Beijing Tongren Hospital, Beijing, China

Keywords: hematology; department hematology; china department; phase; university

Journal Title: Hematological Oncology
Year Published: 2019

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.